The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.2166033538338
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi:10.1016/s0140-6736(17)33326-329395269
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, Version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(4):504–535. doi:10.6004/jnccn.2017.005028404761
   PubMed Web of Science ®Google Scholar
• Yuan M, Huang LL, Chen JH, Wu J, Xu Q. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. 2019;4:61. doi:10.1038/s41392-019-0099-931871778
   PubMed Web of Science ®Google Scholar
• Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–695. doi:10.1016/j.cell.2006.11.00117110329
   PubMed Web of Science ®Google Scholar
• Jeong JH, Ojha U, Lee YM. Pathological angiogenesis and inflammation in tissues. Arch Pharm Res. 2021;44(1):1–15. doi:10.1007/s12272-020-01287-233230600
   PubMed Web of Science ®Google Scholar
• Daum S, Hagen H, Naismith E, Wolf D, Pircher A. The role of anti-angiogenesis in the treatment landscape of non-small cell lung cancer - new combinational approaches and strategies of neovessel inhibition. Front Cell Dev Biol. 2020;8:610903. doi:10.3389/fcell.2020.61090333469537
   PubMed Web of Science ®Google Scholar
• Pathak AP, Hochfeld WE, Goodman SL, Pepper MS. Circulating and imaging markers for angiogenesis. Angiogenesis. 2008;11(4):321–335. doi:10.1007/s10456-008-9119-z18925424
   PubMed Web of Science ®Google Scholar
• Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155(3):739–752. doi:10.1016/s0002-9440(10)65173-510487832
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409–426. doi:10.1007/s10456-017-9562-928660302
   PubMed Web of Science ®Google Scholar
• van Ree JH, Jeganathan KB, Malureanu L, van Deursen JM. Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation. J Cell Biol. 2010;188(1):83–100. doi:10.1083/jcb.20090614720065091
   PubMed Web of Science ®Google Scholar
• Wang R, Song Y, Liu X, et al. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A. Int J Oncol. 2017;50(4):1116–1126. doi:10.3892/ijo.2017.388028260026
   PubMed Web of Science ®Google Scholar
• Wang X, Yin L, Yang L, et al. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. FEBS J. 2019;286(24):4889–4909. doi:10.1111/febs.1513431715067
   PubMed Web of Science ®Google Scholar
• Xiong Y, Lu J, Fang Q, et al. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells. Biosci Rep. 2019;39:4. doi:10.1042/bsr20182384
   Web of Science ®Google Scholar
• Jin D, Guo J, Wu Y, et al. UBE2C, directly targeted by miR-548e-5p, increases the cellular growth and invasive abilities of cancer cells interacting with the EMT marker protein zinc finger E-box binding homeobox 1/2 in NSCLC. Theranostics. 2019;9(7):2036–2055. doi:10.7150/thno.3273831037155
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao R, Chi S, et al. UBE2C is upregulated by estrogen and promotes epithelial-mesenchymal transition via p53 in endometrial cancer. Mol Cancer Res. 2020;18(2):204–215. doi:10.1158/1541-7786.Mcr-19-056131662448
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu P, Wang J, et al. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway. Med Oncol. 2015;32(5):149. doi:10.1007/s12032-015-0609-825832867
   PubMed Web of Science ®Google Scholar
• Shen R, Wu T, Huang P, Shao Q, Chen M. The clinicopathological significance of ubiquitin-conjugating enzyme E2C, leucine-rich repeated-containing G protein-coupled receptor, WW domain-containing oxidoreductase, and vasculogenic mimicry in invasive breast carcinoma. Medicine (Baltimore). 2019;98(16):e15232. doi:10.1097/md.000000000001523231008954
   PubMed Web of Science ®Google Scholar
• Tian XL, Kadaba R, You SA, et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature. 2004;427(6975):640–645. doi:10.1038/nature0232014961121
   PubMed Web of Science ®Google Scholar
• Zhang T, Yao Y, Wang J, et al. Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin. Hum Mol Genet. 2016;25(23):5094–5110. doi:10.1093/hmg/ddw27327522498
   PubMed Web of Science ®Google Scholar
• Yang C, Zheng J, Xue Y, et al. The effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 axis regulating glioblastoma angiogenesis. Front Mol Neurosci. 2017;10:437. doi:10.3389/fnmol.2017.0043729375300
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun H, Chen W, He X. Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer. BMC Cancer. 2019;19(1):1252. doi:10.1186/s12885-019-6474-731881864
   PubMed Web of Science ®Google Scholar
• Tu J, Ying X, Zhang D, et al. High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma. Oncotarget. 2017;8(67):111623–111630. doi:10.18632/oncotarget.2288029340079
   PubMedGoogle Scholar
• Yao HH, Wang BJ, Wu Y, Huang Q. High expression of angiogenic factor with G-Patch and FHA Domain1 (AGGF1) predicts poor prognosis in gastric cancer. Med Sci Monit. 2017;23:1286–1294. doi:10.12659/msm.90324828289272
   PubMed Web of Science ®Google Scholar
• Ma L, Yang R, Gu J, Jiang H, Li H. The expression of AGGF1, FOXC2, and E-cadherin in esophageal carcinoma and their clinical significance. Medicine (Baltimore). 2020;99(37):e22173. doi:10.1097/md.000000000002217332925786
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1–8. doi:10.1056/nejm199101033240101
   PubMed Web of Science ®Google Scholar
• Huang W, Yan Y, Liu Y, et al. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1. Signal Transduct Target Ther. 2020;5(1):39. doi:10.1038/s41392-020-0133-y32317629
   PubMed Web of Science ®Google Scholar
• Presta I, Novellino F, Donato A, et al. UbcH10 a major actor in cancerogenesis and a potential tool for diagnosis and therapy. Int J Mol Sci. 2020;21:6. doi:10.3390/ijms21062041
   Web of Science ®Google Scholar
• Dastsooz H, Cereda M, Donna D, Oliviero S, Oliviero A. Comprehensive bioinformatics analysis of UBE2C in cancers. Int J Mol Sci. 2019;20:9. doi:10.3390/ijms20092228
   Web of Science ®Google Scholar
• Guo J, Wu Y, Du J, et al. Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression. Oncogenesis. 2018;7(6):49. doi:10.1038/s41389-018-0054-629904125
   PubMed Web of Science ®Google Scholar
• Yao Y, Li Y, Song Q, et al. Angiogenic factor AGGF1-primed endothelial progenitor cells repair vascular defect in diabetic mice. Diabetes. 2019;68(8):1635–1648. doi:10.2337/db18-117831092480
   PubMed Web of Science ®Google Scholar
• Dong Y, Ma G, Liu Y, Lu S, Liu L. Prognostic value of microvessel density in head and neck squamous cell carcinoma: a meta-analysis. Dis Markers. 2020;2020:8842795. doi:10.1155/2020/884279533062071
   PubMed Web of Science ®Google Scholar
• Mitra D, Bhattacharyya S, Alam N, et al. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast. Breast Cancer Res Treat. 2020;179(2):359–370. doi:10.1007/s10549-019-05482-831686261
   PubMed Web of Science ®Google Scholar
• Rabellino A, Andreani C, Scaglioni PP. Roles of ubiquitination and sumoylation in the regulation of angiogenesis. Curr Issues Mol Biol. 2020;35:109–126. doi:10.21775/cimb.035.10931422936
   PubMed Web of Science ®Google Scholar
• Yao HH, Zhao YJ, He YF, Huang DB, Wang W. Knockdown of AGGF1 inhibits the invasion and migration of gastric cancer via epithelial-mesenchymal transition through Wnt/β-catenin pathway. Cancer Cell Int. 2019;19:41. doi:10.1186/s12935-019-0765-630858758
   PubMed Web of Science ®Google Scholar
• Liu Q, Qiao L, Liang N, et al. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. J Cell Mol Med. 2016;20(9):1761–1769. doi:10.1111/jcmm.1285127027258
   PubMed Web of Science ®Google Scholar
• Zhang X, Cui P, Ding B, et al. Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction. Cancer Gene Ther. 2018;25(1–2):18–26. doi:10.1038/s41417-017-0008-829234153
   PubMed Web of Science ®Google Scholar
• Guo L, Ding Z, Huang N, Huang Z, Zhang N, Xia Z. Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death. Cell Cycle. 2017;16(18):1705–1718. doi:10.1080/15384101.2017.135650728767320
   PubMed Web of Science ®Google Scholar
• Chiang AJ, Li CJ, Tsui KH, et al. UBE2C drives human cervical cancer progression and is positively modulated by mTOR. Biomolecules. 2020;11(1):37. doi:10.3390/biom1101003733396624
   PubMed Web of Science ®Google Scholar
• Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51. doi:10.3389/fnmol.2011.0005122144946
   PubMed Web of Science ®Google Scholar